How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.
Publication|Articles|October 14, 2026
Pharmacy Practice in Focus: Oncology
- October 2026
- Volume 8
- Issue 7
Taking Literacy Literally: Comparing Readability of Chemotherapy Education Materials
Author(s)Sabrina Cannon, PharmD, BCOP
Fact checked by: Cheney Gazzam Baltz
Creating institution-specific, literacy-friendly chemotherapy education sheets resulted in patient education materials with higher readability scores than similar materials from common chemotherapy education sites.
Advertisement
Advertisement
Approximately 1 in 4 American adults has limited literacy skills. National health organizations recommend patient education materials be written in plain language, aiming for a sixth grade reading level. Cancer treatment regimens continue to increase in complexity. Many cancer-specific patient education materials require college-level literacy. Improving readability may enhance patient understanding and encourage informed participation in cancer care. Clinical pharmacists at Huntsman Cancer Institute (HCI) developed institution-specific, literacy-appropriate chemotherapy education materials (CEM) for patients under our care.
Related to this article
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
Nationwide Danish data presented at EASD 2026 link a widening cancer gap in type 2 diabetes largely to obesity-related cancers.
Each October, the pharmacy profession pauses to recognize technicians' decades-long evolution, from on-the-job trainees to nationally certified health care professionals.
In an era of rapidly evolving technology, we remain in a people-powered world.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
Advertisement
Advertisement